MRC1 and female reproductive organ cancer: Another study from Europe performed on 2118 German and Dutch MMR gene mutation carriers revealed a similar tumor spectrum and a high incidence of gynecological cancers: CRC 50%, EC 16%, OC 4,4%, breast 4,4%, urological 3,6%, stomach 1,6% [16].